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Heterogeneity in early language development in autism spectrum disorders (ASD) is clinically 
important and may reflect neurobiologically distinct subtypes. Here we identify a large-scale 
association between multiple coordinated blood leukocyte gene co-expression modules and 
multivariate functional neuroimaging (fMRI) response to speech. Gene co-expression modules 
associated with multivariate fMRI response to speech are different for all pairwise comparisons 
between typically developing toddlers and toddlers with ASD and either poor versus good early 
language outcome. Associated co-expression modules are enriched in genes that are broadly 
expressed in the brain and many other tissues. These co-expression modules are also enriched for 
ASD, prenatal, human-specific and language-relevant genes. This work highlights distinctive 
neurobiology in ASD subtypes with different early language outcomes that is present well before 
such outcomes are known. Associations between neuroimaging measures and gene expression 
levels in blood leukocytes may offer a unique in-vivo window into identifying brain-relevant 
molecular mechanisms in ASD.
Autism spectrum disorders (ASD) are heterogeneous at multiple levels (e.g., genetics, 
cellular and neural systems, cognition, behavior, developmental trajectories, prognosis, 
response to treatment)1–3. This multi-level heterogeneity presents a significant challenge on 
the path towards stratified psychiatry and precision medicine4, 5. One dimension of 
heterogeneity of clinical importance in ASD is early language development and outcome. 
There is a wide spectrum of variability in early language abilities in the ASD population, 
from individuals who remain minimally verbal, to those who have difficulties similar to 
specific language impairment, to those who develop near-typical levels of language function 
6, 7. Early language ability is paramount for better understanding a range of clinical 
phenomena. For example, early language ability is one of the most important predictors of 
early-intervention response and later life outcomes8–12.
An additional challenge lies in studying relationship between macroscale properties of the 
brain and the molecular mechanisms at play in early development, and how this relationship 
may be altered in ASD13. Functional magnetic resonance imaging (fMRI) can be used to 
gain insight into the macroscale, neural-systems level of organization and its association 
with cognitive and behavioral functioning. However, the molecular biological underpinnings 
of this organization are not well understood. Although blood samples are a practical source 
for assaying atypical gene-expression in early ASD development14, 15, a common question 
is how relevant they are for understanding atypical neural processes in ASD. The evidence 
for a genetic basis of ASD is strong16, 17 and genetic variation will likely affect gene 
expression levels in multiple tissues18, including brain and blood. Thus, identifying 
associations between the blood leukocyte transcriptome and neuroimaging phenotypes may 
help shed light on mechanisms affecting early neural systems development in toddlers with 
ASD as compared to typically-developing toddlers. Such an “in-vivo window” onto the 
biology of ASD13 may be able to further our understanding of the mechanisms underlying 
atypical brain development in heterogeneous populations of ASD patients, but may also 
advance translational work targeted at better monitoring treatment response, predicting 
prognosis, and in evaluating clinical trials.
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Here we ask whether large-scale coordinated gene expression in blood leukocytes is 
associated with neural responses to speech as measured with fMRI, and whether this 
association differs between toddlers with ASD and either poor or good early language 
outcome and typically-developing toddlers. A fundamental question for this work is whether 
differences in early language outcome are a biologically relevant basis for stratifying ASD. 
Based on prior work19 suggesting that early language outcome subtypes are underpinned by 
distinct biology, we predict that early language outcome ASD subtypes will show different 
profiles of associations between blood leukocyte gene expression and functional neural 
systems response to speech.
Examining large-scale blood leukocyte transcriptome associations with neuroimaging 
phenotypes in ASD may also identify novel mechanisms involved in ASD. The omnigenic 
model20, much like other viewpoints on polygenic risk21, predicts that large numbers of 
genes are relevant to complex traits like ASD. However, the omnigenic model suggests that 
these genes do not necessarily need to be specific to brain tissue. Genes that are broadly 
expressed in one or more tissues, including brain and blood, are predicted to harbor a large 
amount of the heritability signal and can contribute more to overall risk than the smaller 
number of tissue-specific genes implicated in a complex trait20. Applied to the current 
study, we predict that large-scale coordinated transcriptional activity in the blood leukocyte 
transcriptome could be relevant for explaining neural phenotypes relevant to ASD. The 
omnigenic model predicts that this large-scale transcriptomic signal would be enriched for 
genes that are broadly expressed in the brain and many other tissues.
Results
Group-differentiation in superior temporal cortex response to speech and clinical 
behavioral trajectories over the first 4 years of life
In this study we compared typically-developing toddlers (TD) and age-matched toddlers 
with ASD, whose language abilities were assessed around 3-4 years of age. Toddlers with 
ASD were stratified by poor (“ASD Poor”) or good (“ASD Good”) language outcome. ASD 
Poor is defined by Mullen expressive (EL) and receptive language (RL) T-scores below 1 
standard deviation of typical developing age norms (T<40). In contrast, ASD Good is 
defined by outcome Mullen EL or RL within 1 standard deviation of typical age-norms 
(T≥40) (see Methods). In prior work we showed that this stratification identifies an ASD 
subtype with different developmental trajectories and a reduced left-hemisphere superior 
temporal cortex response to speech, as measured with sleep-fMRI before diagnosis and 
outcome are known19. The current dataset utilizes a subset of toddlers from the prior paper 
(n = 19 ASD Poor; n = 24 ASD Good; n = 21 TD), and adds a similar number of new 
toddlers (n=22 ASD Poor, n=16 ASD Good, and n=16 TD). Thus, we first re-ran 
longitudinal clinical trajectory and fMRI analyses of this combined dataset.
As previously reported19, all longitudinal clinical measures showed evidence of 
subtype*age interactions (except for Mullen Fine Motor and ADOS total), indicating that 
groups differed in the slope of trajectories (see Fig. 1; Supplementary Table 1 for statistics). 
This difference was generally driven by the ASD Poor group, whose downwards trajectories 
are indicative of falling further behind age-appropriate norms. All measures also showed 
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main effects of group and were generally due to all groups differing from one another in a 
hierarchy of ASD Poor as most severe, ASD Good as intermediate, and TD as least severe. 
With the fMRI data, we also find that the previously reported19 hypoactivation in left 
hemisphere superior temporal cortex remains stable in this combined sample (Fig. 2 and 
Supplementary Table 2). Whole-brain between-group analyses did not reveal any regions 
differentiating the groups. However, the lack of effects in this context are likely to be due to 
low statistical power for whole-brain between-group comparisons22.
Lack of group-differentiation within gene expression data alone
The total sample of n=41 ASD Poor, n=40 ASD Good, and n=37 TD was the largest dataset 
of toddlers for whom both fMRI and gene expression data were available. We next assessed 
whether differences in blood leukocyte gene expression might reflect this different neural 
systems organization between the two ASD language-outcome subtypes. First, we assessed 
differential expression (DE) between subtypes at the level of individual genes. After 
correction for multiple comparison, no genes were identified as DE for any pairwise group 
comparison (Supplementary Table 3). Next, we utilized weighted gene co-expression 
network analysis (WGCNA) to reduce redundancy between the 14,313 genes, down to 21 
discrete co-expression modules. Co-expression modules are summarized by the first 
principal component score, also known as the module eigengene (ME)23. Similar to the DE 
analysis at the gene level, there were no ME differences between the two ASD subtypes 
(Supplementary Table 3). Thus, examining blood leukocyte gene expression data in isolation 
does not significantly differentiate the groups at the current sample sizes. We next turned to 
examining associations between gene expression and functional neuroimaging phenotypes.
Large-scale blood leukocyte gene co-expression module association with fMRI response 
to speech
Multivariate analysis of association between co-expression modules and whole-brain voxel-
wise patterns of activation was implemented with partial least squares (PLS) analyses. Of 
the 63 total latent variable (LV) co-expression-fMRI pairs, PLS identified only one LV pair 
with a statistically significant association after multiple comparison correction (LV1: d = 
65.47, p = 1.99e-4, FDR q = 0.0125; see Supplementary Table 4 for statistics for all PLS LV 
pairs). LV1 accounts for 20.13% of the covariance between gene expression and fMRI data 
and is spatially distributed across a number of cortical regions highly relevant to speech, 
language24, 25 (e.g., primary auditory cortex, superior temporal sulcus, inferior frontal 
gyrus, ventral premotor cortex, insula), visual and sensorimotor areas (e.g., primary visual 
cortex, superior parietal cortex, primary somatomotor cortex, premotor cortex), cognitive 
control (dorsolateral prefrontal cortex), and ‘social brain’ circuitry overlapping with key 
areas of the default mode network (e.g., posterior cingulate cortex, medial prefrontal cortex, 
right temporo-parietal junction, superior temporal sulcus) (Fig. 3a). Subcortical regions such 
as the striatum and thalamus were also implicated and are highly relevant for language 
processes such as vocal learning25, 26. For example, Area X in song birds is linked to vocal 
learning and is homologous with human dorsal striatum26.
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Extent of non-zero associations across co-expression modules
To better understand the most important co-expression modules for the PLS LV1 result, we 
first identified what we call ‘non-zero’ association modules. Non-zero modules are defined 
as gene co-expression modules which have gene co-expression-fMRI correlations with 95% 
confidence intervals (CI) that exclude a correlation of 0. Non-zero modules comprise about 
half of all modules analyzed (11/21; 52%) (Fig. 3b; Supplementary Table 4). The remaining 
modules (10/21; 48%) are referred to as ‘zero’ modules, defined as gene co-expression 
modules for which a correlation of 0 lies within the 95% CIs. Zero modules contribute little 
to and/or are unreliable in how they contribute to LV1. Non-zero modules cover a majority 
(61%) of the transcriptome considered for the WGCNA analysis. This widespread coverage 
indicates a coordinated and large-scale signal spanning large parts of the blood leukocyte 
transcriptome associated with macroscale functional neural response to speech measured 
with fMRI.
Most non-zero modules can be characterized by a variety of biological processes generally 
falling within categories such as translation, transcription, cell cycle, immune, inflammation, 
signal transduction, and cytoskeleton processes. However, enrichments differ substantially 
depending on the module (Fig. 3b; see Supplementary Table 5 for a complete description of 
enrichments for each module). For instance, non-zero modules M2, M8, and M11 are 
primarily translation and transcription modules, while M1 and M10 have enrichments for 
many of these terms, but not translation and transcription. These biological processes have 
all been implicated as important in autism. For example, translation processes are affected in 
many syndromic forms of ASD (e.g., Fragile X Syndrome, Tuberous Sclerosis)27. Many 
high-confidence ASD-risk genes are known to affect transcription processes (e.g., CHD8)28, 
29. Cell cycle processes are involved in aberrant early cell proliferation and increased early 
brain growth in ASD13, 14. Immune and inflammation processes have been linked to ASD 
via various lines of evidence30–32. These results supports the idea that ASD-relevant 
biological processes can be assayed in blood leukocytes and are associated with early 
developing large-scale functional neuroimaging phenotypes.
Lack of overlap in non-zero modules across ASD subtypes and TD
The majority of non-zero modules are present only in one group (9/11; 81%). In fact, only 
TD and ASD Poor show evidence of non-zero modules. No non-zero modules are present 
for the ASD Good subtype. Two (18%) non-zero modules are present in both TD and ASD 
Poor and are correlated in the same direction. However, the extent of this overlap is not 
statistically significant (enrichment odds ratio (OR) = 1.67, p = 0.65) (Fig. 3b). This result 
suggests that different biological mechanisms within each group may underpin the 
variability observed in macroscale language-relevant fMRI phenotypes. To further test the 
importance of the ASD language outcome subtype distinction, we next tested whether a 
simple case–control distinction could enhance sensitivity in detecting gene co-expression–
fMRI relationships. This case–control PLS analysis was not able to identify any statistically 
significant LV pairs at FDR q<0.05 correction for multiple comparisons (Supplementary 
Table 4). Thus, using early language outcomes as a stratifier in ASD appears to substantially 
enhance sensitivity for detecting gene co-expression–fMRI relationships.
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Non-zero modules are enriched for broadly expressed genes
We next examined what class of genes likely heavily contributes to the non-zero modules. 
Based on ideas from the omnigenic model20, genes that are broadly expressed, i.e. 
expressed in many tissues including the brain, could also be expressed and measurable in 
blood leukocytes and, therefore, could be of high relevance for these non-zero modules 
associated with a functional neuroimaging phenotype. Remarkably, we find that 81% (9/11) 
of non-zero modules are enriched for broadly expressed genes (OR = 184.5, p = 1.87e-4). 
All modules enriched for broadly expressed genes were also non-zero modules (Fig. 4b). In 
contrast, tissue-specific gene lists (e.g., brain, whole blood, lymphocyte) were not heavily 
enriched in many modules nor over-represented in non-zero modules (brain-specific 
modules: OR = 0, p = 1; whole blood-specific modules: OR = 0.6, p = 0.96; lymphocyte-
specific modules: OR = 4.44, p = 0.53) (Fig. 4b). In addition to running these enrichments at 
the level of overlap amongst modules, we also ran tests for overlap at the gene level. Around 
44% of all broadly expressed genes are present in non-zero modules, amounting to a highly 
significant enrichment (OR = 3.58, p = 1.48e-93). Whole-blood and lymphocyte-specific 
genes also showed evidence of enrichment in non-zero modules (blood OR = 4.79, p = 
1.57e-18; lymphocyte OR = 2.82, p = 1.94e-8), though whole-blood-specific genes also 
showed enrichment in zero modules (Fig. 4a). As shown in Fig. 4b, the whole-blood and 
lymphocyte-specific enrichments are likely driven by genes within 1-2 non-zero modules 
(e.g., M1, M6, M17). In contrast, the enrichment in broadly expressed genes is driven by 
genes spread across nearly every single non-zero module.
Non-zero modules are enriched for differentially expressed genes in a song bird vocal 
learning model
Given the relationship between expression of genes in non-zero modules and language-
relevant functional neuroimaging phenotypes, we next looked to validate whether these 
genes are brain-relevant and conserved in an animal model of vocal learning. Vocal learning 
is a language-relevant ability shared between humans and songbirds and has been 
extensively examined 25, 26, 33. Here we tested whether genes in our non-zero modules 
show overlap with DE genes from subcortical Area X of singing versus non-singing 
songbirds. Re-analysis of data from Hilliard et al.33 identified 1,267 DE genes in Area X 
and of these, 902 overlap with the genes examined in the main PLS analysis. Area X is 
thought to be homologous with human striatal areas26 (Fig. 1a). Strikingly, 33% of the DE 
genes in Area X are present in our non-zero modules (OR = 1.77, p = 0.002). In contrast, no 
such enrichment was present in zero modules (OR = 1.37, p = 0.13) (Fig. 5a). Most of the 
non-zero enrichment was driven specifically by module M10, as no other non-zero module 
was specifically enriched in songbird-DE genes (Fig. 5b). These results suggest that a subset 
of genes in non-zero modules are indeed brain-relevant and conserved between humans and 
songbirds, which both have an ability for vocal learning.
Non-zero modules are enriched for transcriptionally human-specific genes
Language requires more than vocal learning and is indeed a uniquely human ability. 
Therefore, it is possible that components of language ability may be reflected in neural 
differences between humans and our closest non-human primate relatives (e.g., 
Lombardo et al. Page 6
Nat Neurosci. Author manuscript; available in PMC 2019 May 26.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
chimpanzees) which do not possess language34. We therefore investigated whether non-zero 
modules are enriched for genes that are DE in cortical tissue of humans versus chimpanzees 
(‘human-specific’ genes). Using two lists of such ‘human-specific’ genes obtained from 
independent studies34, 35 and which minimally overlap (4.38%), we find that non-zero 
modules are significantly enriched on both lists, with 33-34% of human-specific genes 
overlapping with genes from non-zero modules (OR>1.73, p <0.0115) (Fig. 5a). These 
enrichments are driven by M13, as no other specific modules were enriched across both 
human-specific gene lists (Fig. 5b). In contrast, no enrichment of human-specific genes is 
present in zero modules (OR<1.11, p >0.85; Fig. 5a). These results suggest that 
transcriptional activity of human-specific genes in blood leukocytes is linked to language-
relevant fMRI phenotypes measured in TD and ASD toddlers with varying early language 
abilities.
Non-zero modules are enriched for highly active prenatal co-expression modules 
associated with ASD
Several lines of evidence point towards ASD pathophysiology having key impact on prenatal 
brain development13, 36–38. We therefore examined whether non-zero modules are 
enriched for genes that are members of co-expression modules that show high levels of 
prenatal expression and that possess a number of highly-penetrant ASD-associated genes. 
Using lists from two independent studies of the BrainSpan atlas39 examining either cortical-
only37 or cortical and subcortical regions36, we find that approximately 32% of genes in 
prenatal and ASD-associated co-expression modules also appear in non-zero modules 
(OR>1.7, p <0.0056) (Fig. 5a), whereas only 15-17% are present in zero modules (OR<1.19, 
p>0.74). Non-zero modules M15 and M10 drove the enrichment, as no other non-zero 
modules showed evidence of enrichment for genes in either ASD-associated prenatal gene 
lists (Fig. 5b). Overall, this evidence supports the idea some of the genes present in non-zero 
modules are also genes that are members of prenatally active and ASD-associated co-
expression modules.
Non-zero modules are enriched with genes from ASD-downregulated co-expression 
modules from frontal and temporal cortex tissue
While establishing that non-zero modules overlap with prenatally relevant co-expression 
modules that harbor ASD-relevant genes, a caveat to this result is that those prenatal, ASD-
associated co-expression modules were identified from the BrainSpan dataset39, which for 
obvious reasons does not contain prenatal tissue from ASD donors. Thus, to more directly 
connect non-zero modules with cortical gene expression in diagnosed ASD patients, we used 
gene-expression data from post-mortem frontal and temporal cortical tissue of ASD 
patients40. Non-zero modules are enriched for genes that are members of ASD-
downregulated frontal and temporal cortex co-expression modules (OR = 1.70, p = 0.03). 
Enrichments at trend levels were also seen for genes from ASD-upregulated co-expression 
modules (OR = 1.64, p = 0.0502, FDR q = 0.0586) (Fig. 5a). However, no specific non-zero 
modules seemed to drive this enrichment (Fig. 5b). While zero modules were not enriched in 
genes from ASD-downregulated modules (OR = 1.15, p = 0.75), zero modules were 
enriched for genes from ASD-upregulated modules (OR = 1.79, p = 2.80e-5) (Fig. 5a). 
These results further point towards the ASD- and brain-relevance of genes identified via 
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their non-zero association between expression in blood leukocytes and language-relevant 
functional neuroimaging phenotypes.
Non-zero modules with preservation of network structure between ASD blood and cortical 
tissue
Utilizing the same gene-expression dataset from post-mortem cortical tissue from ASD 
patients40, we next examined whether co-expression network structure of non-zero modules 
identified in blood might be preserved in ASD frontal and temporal cortical tissue. This is 
important, as it highlights specific modules where co-expression network connectivity 
patterns are similar between blood leukocytes and brain tissue. While non-zero modules M8 
and M11 showed moderate evidence of preservation (2< Zsummary <6), the non-zero M2 
module was the highest ranking of all modules with evidence of high-moderate preservation 
(Zsummary = 8.1) (Supplementary Fig. 1). M2 is highly enriched for the term ‘translation in 
mitochondria’ (Supplementary Table 5) and many of M2’s hub genes encode proteins that 
are localized to mitochondria (e.g., MRPS12, NDUFS3, NDUFB8, HINT2, MRPL14) 
(Supplementary Table 6). This evidence could be relevant in light of possible mitochondrial 
dysfunction in autism41. Other notable M2 hub genes are DGCR6 and BOLA2. Both are 
located within prominent ASD-associated CNV regions of 22q11.21 (DGCR6) and 16p11.2 
(BOLA2)42. Interestingly with regard to evolutionarily accelerated human-specific genes, 
BOLA2 is known for human-specific duplications and shows upregulated expression in 
human versus chimpanzee induced pluripotent stem cells (iPSCs)43, 44. In patients with 
16p11.2 CNVs, 96% of breakpoints include human-specific duplications of BOLA244. 
Deletions and duplications of 16p11.2 are linked to language and its associated neural 
circuitry45–47. Thus, the evidence here could suggest that BOLA2 is an important ASD-
relevant 16p11.2 locus, but also is more generally relevant for the human-specific capacity to 
develop language and the neural systems supporting that development.
Non-zero modules are enriched for ASD de novo protein-truncating variants and cortically 
ASD-downregulated co-expression modules
We next tested non-zero modules for enrichments with different classes of genetic variants 
associated with ASD. We first examined enrichment with high-penetrance rare de novo 
protein truncating variants (dnPTVs). Amongst the genes highlighted by Kosmicki et al.,48 
with ≥2 dnPTVs in ASD, 43% are also present in non-zero modules, resulting in an 
enrichment at trend level significance (OR = 2.58, p = 0.08, FDR q = 0.0915). The lack of 
significant enrichment may be due to the limited number of known dnPTVs that overlap 
with the subset of genes considered in our analysis (i.e. 28). When we relax the criterion to 
≥1 dnPTVs in ASD but add the constraint that the gene should also have a probability of 
loss-of-function intolerance (pLI)≥0.949, this enabled us to study a larger set (155) of 
putative ASD-relevant dnPTVs. Under this criterion, we find a significant enrichment of 
these ASD risk genes in non-zero modules (OR = 2.01, p = 0.02) (Fig. 5a), including ADNP, 
ANKRD11, DYRK1A, ILF2, KDM5B, KDM6B, MED13L, PHF2, PTEN, SPAST, 
SUV420H1, TRIP12, WDFY3, ZC3H4. Non-zero module M10 is the primary driver behind 
this enrichment (Fig. 5b) and includes ADNP, ANKRD11, DYRK1A, KDM5B, TRIP12, 
and ZC3H4. Of these notable M10 genes, ADNP is within the top 20 hub genes 
(Supplementary Table 6). In contrast, zero modules were not enriched for these ASD risk 
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genes, either amongst the criteria of ≥2 dnPTVs or with ≥1 dnPTVs and pLI ≥0.9 (OR < 
1.82, p > 0.24) (Fig. 5a). In addition, and contrary to the enrichment with ASD-associated 
dnPTVs, we could not find any enrichment amongst the 543 ASD-associated genes 
annotated on SFARI Gene (https://gene.sfari.org)50 for non-zero (OR = 1.36, p = 0.66) or 
zero modules (OR = 1.26, p = 0.44) (Fig. 5a). This evidence suggests that some high-
penetrance ASD-associated genes are detectable within blood leukocyte gene expression 
data and show strong association to in-vivo functional neuroimaging phenotypes relevant for 
early language heterogeneity in ASD.
Non-zero modules are enriched for FMRP and CHD8 targets
While non-zero modules do not contain some of the most well-known and highly-penetrant 
ASD-associated genes, such as FMR1 and CHD8, non-zero modules may nevertheless 
overlap with the molecular networks linked to these genes. One way to examine this 
hypothesis is through testing non-zero modules for enrichment with downstream targets of 
these highly important genes. Non-zero modules are highly enriched for both FMRP and 
CHD8 targets across two different target lists (OR>1.89, p<0.0269) (Fig. 5a). Numerous 
modules drive these enrichments, such as M10 and M15 for FMRP targets and M10, M8, 
M13, and M15 for CHD8 targets (Fig. 5b). In contrast, zero modules were not enriched for 
target genes of either FMRP or CHD8 (Fig. 5a). These results suggest that non-zero modules 
also contain genes that are members of FMRP and CHD8-related networks.
Broadly expressed genes are a prominent source of signal driving enrichments
Finally, given the prominent overlap between broadly expressed genes and non-zero 
modules, we tested whether many of the other enrichments with non-zero modules were 
driven by broadly expressed genes. We first examined the enrichment of broadly expressed 
genes with all of the gene lists already tested. Remarkably, we found that nearly all gene 
lists enriched in non-zero modules are also highly enriched in broadly expressed genes (Fig. 
5a). Furthermore, once broadly expressed genes are removed from these lists, the 
enrichments with non-zero modules largely disappear (Supplementary Fig. 2). This suggests 
that broadly expressed genes drive the enrichments of these lists in non-zero modules.
Discussion
Here we find one large-scale association between coordinated gene co-expression modules 
in blood leukocytes with multivariate fMRI response to speech. Highlighting the 
distinctiveness of ASD language outcome subtypes, we find that blood leukocyte co-
expression modules associated with multivariate fMRI response to speech are different for 
all pairwise comparisons between groups of TD toddlers or toddlers with ASD and either 
poor or good language outcome. Given the early ages when blood samples and fMRI data 
were collected, it is clear that this association manifests well before stable diagnoses and 
final language outcomes are known. Co-expression modules of importance in TD but not 
ASD may signal normative biological processes associated with the development of 
language-related neural circuitry. These normative processes may be affected in ASD. In 
addition, modules that diverge between ASD subtypes may indicate risk or protective 
mechanisms that push different ASD individuals towards different early developmental 
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language outcomes. Thus, in contrast to the idea that ASD is a uniform condition with 
similar underlying biological mechanisms in all diagnosed individuals, these results indicate 
that a behavioral stratifier such as early language outcome holds important information to 
help understand how the underlying biology may be differentially linked to the way 
macroscale neural systems develop.
These findings may be of high translational importance. Both neuroimaging methods and 
blood sampling to quantify the leukocyte transcriptome with high-throughput techniques are 
feasible to collect from ASD patients with different levels of impairment and at early ages. 
In-vivo examination of the molecular mechanisms and their associations with higher-level 
macroscale neural systems and heterogeneity in clinical phenotypes will be important for 
furthering progress towards precision medicine13. Endeavors such as evaluating early-age 
treatment response, monitoring clinical trials, developing prediction tools for diagnosis and 
prognosis can all be facilitated with this approach to understanding links between gene 
expression, macroscale neural systems, and behavioral levels of analysis. Future work will 
be necessary to determine whether similar associations are present in older children and 
adults with ASD. Given the inability to directly and non-invasively assay gene expression 
from brain tissue in living patients, the current approach offers a novel in-vivo window into 
how molecular mechanisms are associated with ongoing and dynamic macroscale neural 
systems development across the lifespan in ASD.
Another striking feature of these results is the large-scale nature of the association that 
covers a majority of the blood leukocyte transcriptome considered by the co-expression 
analysis. This feature matches predictions from the omnigenic model20. The omnigenic 
model suggests that for any complex trait or disorder (e.g., ASD), the majority of heritability 
signal is spread widely throughout most of the genome. The omnigenic model also suggests 
that the numerous widespread ‘peripheral’ genes of small effect likely interact within gene 
regulatory networks with a smaller set of ‘core’ genes with much larger effect. Here we find 
evidence that higher-impact rare dnPTVs in ASD that are intolerant to loss of function 
mutations are enriched amongst non-zero modules. Furthermore, we also find that many 
targets of FMRP and CHD8 are enriched in non-zero modules. Thus, the massive number of 
genes present within non-zero modules may point to a large peripheral background of small 
risk common variants that could work en masse and interact in important ways with genes 
that can be higher-impact core mechanisms.
The omnigenic model makes another key prediction, namely that the such associations can 
be detectable in many tissue types other than the brain, such as blood leukocytes. The 
omnigenic model suggests that a large percentage of the genes associated with a complex 
trait are likely to be broadly expressed genes. Here we find evidence of large overlap 
between broadly expressed genes and non-zero modules - around 44% of all broadly 
expressed genes exist within non-zero association modules. In contrast to the fact that nearly 
all non-zero modules (e.g., 81%) were enriched with broadly expressed genes, only 2 non-
zero modules (e.g., 18%) were enriched in lymphocyte-specific genes. Thus, this large-scale 
gene co-expression-fMRI association is largely driven by genes broadly expressed in the 
brain and many other tissues rather than lymphocyte-specific genes. While we observed 
enrichments between non-zero modules and genes implicated in vocal learning, human-
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specific genes, ASD-associated prenatal co-expression modules, cortically ASD-
downregulated co-expression modules, ASD dnPTVs, and FMRP and CHD8 targets, most 
of these enrichments likely emerged because each gene list is heavily enriched in broadly 
expressed genes. Removing broadly expressed genes from these lists results in elimination 
of nearly all significant enrichments with non-zero modules. Overall, these results highlight 
the importance of broadly expressed genes as a novel class of mechanisms for further study 
in ASD.
There are some limitations and caveats to keep in mind. First, the number of genes 
investigated in the final co-expression and PLS analyses are a subset of the total number of 
genes in the entire genome that could be considered. Therefore, while non-zero modules do 
cover a large proportion of the genes examined in the analysis, they do not cover a large 
majority of the entire genome. The extent of coverage of non-zero modules is certainly 
compatible with ideas about polygenic architecture behind complex neural phenotypes21. 
However, the coverage of non-zero modules cannot be interpreted with respect to the 
omnigenic model in terms of sheer size. The current study does however evaluate 
predictions from the omnigenic model, particularly with respect to the importance of broadly 
expressed genes. However, this result can also be consistent with polygenic viewpoints, 
particularly if most of the polygenic associations reside within broadly expressed genes. 
Second, because the expression data is measured from a non-neural tissue, many brain-
specific genes are not considered in the analyses. Thus, the current dataset cannot say 
anything about the importance or lack thereof with regard to brain-specific genes, nor can 
we make comparisons about the relative importance of broadly expressed genes versus 
brain-specific genes.
To summarize, we identify a large-scale association between multiple coordinated blood 
leukocyte gene co-expression modules and multivariate fMRI response to speech. 
Associated co-expression modules are different for all pairwise comparisons between TD 
toddlers and toddlers with ASD and good versus poor early language outcome. The 
associated co-expression modules are highly enriched in broadly expressed genes as well as 
ASD, prenatal, human-specific, and language-relevant genes. These results are congruent 
with predictions from polygenic and omnigenic models and suggest that gene expression in 
peripheral cells like blood leukocytes are associated with in-vivo functional neural response 
to language that differentiates ASD toddlers with poor versus good early language 
outcomes. The study showcases a novel in-vivo approach that could be used in future work 
towards precision medicine goals.
Methods
Participants
This study was approved by the Institutional Review Board at University of California, San 
Diego. Parents provided written informed consent according to the Declaration of Helsinki 
and were paid for their participation. Identical to the approach used in our earlier studies14, 
15, 19, 51, 52, toddlers were recruited through two mechanisms: community referrals (e.g., 
website) or a general population-based screening method called the 1-Year Well-Baby 
Check-Up Approach53 that allowed for the prospective study of ASD beginning at 12 
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months based on a toddler’s failure of the CSBS-DP Infant-Toddler Checklist54, 55. All 
toddlers were tracked from an intake assessment around 12 months and followed roughly 
every 12 months until 3–4 years of age. All toddlers, including normal control subjects, 
participated in a series of tests collected longitudinally across all visits, including the Autism 
Diagnostic Observation Schedule (ADOS; Module T, 1, or 2)56, the Mullen Scales of Early 
Learning57, and the Vineland Adaptive Behavior Scales58. All testing occurred at the 
University of California, San Diego Autism Center of Excellence (ACE). No randomization 
procedures were implemented as part of the data collection process. Data collection and 
analyses were not performed blind to the conditions of the experiment.
A total of n=118 toddlers were scanned with fMRI and had available gene expression data. 
No statistical methods were used to pre-determine sample sizes, but our sample sizes are 
currently amongst the largest of any fMRI study to date on ASD at very early ages in 
toddlerhood. From these 118 toddlers, n=81 ASD individuals were examined and were split 
into 2 language outcome subtypes. n=41 individuals with ASD (34 male, 7 female) were 
classified as ‘poor’ language outcome (ASD Poor), based on the criteria of having both 
Mullen EL and RL T-scores more than 1 standard deviation below the norm of 50 (i.e. T<40) 
at the final testing time-point (mean age at fMRI scan = 29.53 months, SD at fMRI scan = 
8.04, range = 12-46 months). Another n=40 individuals with ASD (30 male, 10 female) 
were classified as ‘good’ language outcome (ASD Good), based on having either Mullen EL 
or RL T-scores greater than or equal to 40 (i.e. T ≥ 40) at the final testing time-point (mean 
age at fMRI scan = 29.73 months, SD at fMRI scan = 8.51, range = 12-45 months). The 
usage of the term ‘Good’ here is not used to refer to ability level in absolute terms, but more 
reflects ability relative to the ASD Poor subgroup. These ASD subtypes were compared to 
n=37 typically-developing toddlers (21 male, 16 female; mean age at fMRI scan = 26.19 
months, SD at fMRI scan = 10.20, range = 12-45 months). ASD subtypes and TD did not 
statistically differ in age at the time of scanning (F(2,115) = 1.87, p = 0.15). For more 
demographic and phenotypic information, please see Supplementary Table 7.
Blood Sample Collection, RNA extraction, quality control and samples preparation
Four to six milliliters of blood was collected into EDTA-coated tubes from toddlers on visits 
when they had no fever, cold, flu, infections or other illnesses, or use of medications for 
illnesses 72 hours prior blood draw. Blood samples were passed over a LeukoLOCK™ filter 
(Ambion, Austin, TX, USA) to capture and stabilize leukocytes and immediately placed in a 
20°C freezer. Total RNA was extracted following standard procedures and manufacturer’s 
instructions (Ambion, Austin, TX, USA). LeukoLOCK disks (Ambion Cat #1933) were 
freed from RNA-later and Tri-reagent (Ambion Cat #9738) was used to flush out the 
captured lymphocyte and lyse the cells. RNA was subsequently precipitated with ethanol 
and purified though washing and cartridge-based steps. The quality of mRNA samples was 
quantified by the RNA Integrity Number (RIN), values of 7.0 or greater were considered 
acceptable59, and all processed RNA samples passed RIN quality control. Quantification of 
RNA was performed using Nanodrop (Thermo Scientific, Wilmington, DE, USA). Samples 
were prep in 96-well plates at the concentration of 25 ng/µl.
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Gene expression and data processing
RNA was assayed at Scripps Genomic Medicine (La Jolla, CA, USA) for labeling, 
hybridization, and scanning using the Illumina BeadChips pipeline (Illumina, San Diego, 
CA, USA) per the manufacturer’s instruction. All arrays were scanned with the Illumina 
BeadArray Reader and read into Illumina GenomeStudio software (version 1.1.1). Raw data 
was exported from Illumina GenomeStudio, and data pre-processing was performed using 
the lumi package60 for R (http://www.R-project.org) and Bioconductor (http://
www.bioconductor.org)61. Raw and normalized data are part of larger sets deposited in the 
Gene Expression Omnibus database (GSE42133; GSE111175).
A larger primary dataset of blood leukocyte gene expression was available from 383 samples 
from 314 toddlers with the age range of 1-to-4 years old. The samples were assayed using 
the Illumina microarray platform on three batches. The datasets were combined by matching 
the Illumina Probe ID and probe nucleotide sequences. The final set included a total of 
20,194 gene probes. Quality control analysis was performed to identify and remove 23 
outlier samples from the dataset. Samples were marked as outlier if they showed low signal 
intensity (average signal two standard deviations lower than the overall mean), deviant 
pairwise correlations, deviant cumulative distributions, deviant multi-dimensional scaling 
plots, or poor hierarchical clustering, as described elsewhere14. The high-quality dataset 
included 360 samples from 299 toddlers. High reproducibility was observed across technical 
replicates (mean Spearman correlation of 0.97 and median of 0.98). Thus, we randomly 
removed one of each of two technical replicates from the primary dataset. From the subjects 
in the larger primary dataset, n=118 also had task-fMRI data and thus a total of n=105 from 
the Illumina HT12 platform along with n=13 from the Illumina WG6 platform were used in 
this study. Batch was not asymmetrically distributed across one subgroup more than another, 
as chi-square analyses on the contingency table between subgroup and batch show no effect 
(χ2(4) = 4.772, p = 0.3115). ASD subtypes and TD toddlers also did not statistically differ 
in age at the time of blood sampling (F(2,115) = 1.74, p = 0.17). The 20,194 probes were 
then collapsed to 14,313 genes based on picking the probe with maximal mean expression 
across samples. Data were quantile normalized and then adjusted for batch effects, sex, and 
RIN. This batch, sex, and RIN adjusted data were utilized in all further downstream 
analyses. We also checked for differences in proportion estimates of different leukocyte cell 
types (i.e. neutrophils, B cells, T cells, NK cells, and monocytes) using the CellCODE 
deconvolution method62, but found no evidence of differences across groups for any cell 
type (see Supplementary Table 8). In addition to the primary analyses using WGCNA, 
differential expression analysis at the level of individual genes was also conducted using 
limma63, and DE genes were identified if they passed Storey FDR q<0.0564. Data 
distributions were assumed to be normal but this was not formally tested for each gene. 
Further enrichment tests were used annotate which co-expression modules are enriched for 
such DE genes.
Weighted Gene Co-Expression Network Analysis
We reduced the number of features in the gene expression dataset from 14,313 genes down 
to 21 modules of tightly co-expressed genes. This data reduction step was achieved using 
weighted gene co-expression network analysis (WGCNA), implemented within the 
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WGCNA library in R23. Correlation matrices estimated with the robust correlation measure 
of biweight midcorrelation were computed and then converted into adjacency matrices that 
retain the sign of the correlation. These adjacency matrices were then raised to a soft power 
of 16 (see Supplementary Fig. 3a). This soft power was chosen by finding the first soft 
power where a measure of R2 scale-free topology model fit saturates at least above R2 > 
0.865 and where the slope was between -1 and -266. The soft power thresholded adjacency 
matrix was then converted into a topological overlap matrix (TOM) and then a TOM 
dissimilarity matrix (e.g., 1-TOM). The TOM dissimilarity matrix was then input into 
agglomerative hierarchical clustering using the average linkage method. Gene modules were 
defined from the resulting clustering tree, and branches were cut using a hybrid dynamic tree 
cutting algorithm (deepSplit parameter = 4) (see Supplementary Fig. 3b). Modules were 
merged at a cut height of 0.2, and the minimum module size was set to 100. Only genes with 
a module membership was r > 0.3 were retained within modules. For each gene module, a 
summary measure called the module eigengene (ME) was computed as the first principal 
component of the scaled (standardized) module expression profiles. We also computed 
module membership for each gene and module. Module membership indicates the 
correlation between each gene and the module eigengene (see Supplementary Table 6). 
Genes that could not be clustered into any specific module are left within the M0 module, 
and this module was not considered in any further analyses. Analysis of group differences in 
MEs were also conducted using linear models and correction for multiple comparisons at 
FDR q<0.05 (see Supplementary Table 3; Supplementary Fig. 4). Data distributions were 
assumed to be normal but this was not formally tested for each module. Further WGCNA 
analyses were run separately within each group in order to check for preservation of detected 
modules across groups at a soft power threshold of 20. These analyses all indicated high 
levels of preservation (Zsummary>10)67 across nearly all detected modules for each 
pairwise group comparison (see Supplementary Fig. 5).
fMRI Data Acquisition and Task Design
The fMRI task was identical to that used in our previously published studies19, 68–70 and 
consisted of three types of speech stimuli (complex forward speech, simple forward speech, 
and backward speech) as well as rest blocks interspersed between task blocks to forestall 
possible habituation across blocks. Blocks were 20 seconds in duration. All speech 
conditions were created using the same female speaker. Two contrasts of interest were 
analyzed in this study: all speech conditions versus rest and forward (simple + complex) 
versus backward speech. At early language learning ages, when neonates, infants, and 
toddlers are not yet experts at language, forward and backward speech both activate 
language-relevant temporal areas; thus, specific comparisons between them tend to be non-
significant70, 71. Therefore, forward and backward speech stimuli both appear to be 
effective in stimulating language-sensitive cortices, by perhaps both being treated as 
potentially language-relevant by the language-inexperienced infant and toddler brain. Thus, 
although we have specifically analyzed both contrasts, because of this age-related caveat for 
forward versus backward speech, our main contrast of interest was all speech versus rest.
Imaging data were collected on a 1.5 Tesla General Electric MRI scanner during natural 
sleep at night; no sedation was used. High-resolution T1-weighted anatomical scans were 
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collected for warping fMRI data into standard atlas space. Blood oxygenation level-
dependent (BOLD) signal was measured across the whole brain with echoplanar imaging 
during the language paradigm (echo time = 30 ms, repetition time = 2,500 ms, flip angle = 
90 degrees, bandwidth = 70 kHz, field of view = 25.6 cm, in-plane resolution = 4 x 4 mm, 
slice thickness = 4 mm, 31 slices).
Analysis of head motion via framewise displacement (FD) and DVARS indicated that head 
motion was minimal (mean FD<0.25) for nearly all subjects in all groups (ASD Good mean 
= 0.11 mm, sd = 0.23; ASD Poor mean = 0.07 mm, sd = 0.08; TD mean = 0.07 mm, sd = 
0.03) and that groups did not differ in either mean FD (F(2,115) = 1.12, p = 0.33) or mean 
DVARS (F(2,115) = 1.93, p = 0.15; ASD Good mean = 8.81, sd = 2.85; ASD Poor mean = 
8.61, sd = 2.57; TD mean = 7.75, sd = 2.01).
fMRI Data Analyses
Preprocessing of functional imaging data was implemented within the Analysis of 
Functional NeuroImages (AFNI) software package. The preprocessing pipeline was 
comprised of motion correction, normalization to Talairach space, and smoothing (8mm full-
width at half-maximum (FWHM) Gaussian kernel). First-level and second-level mass-
univariate whole-brain activation analyses were modeled with the general linear model 
(GLM) in SPM8 (http://www.fil.ion.ucl.ac.uk/spm/). Events in first-level models were 
modeled using the canonical hemodynamic response function and its temporal derivative. 
All first-level GLMs included motion parameters as covariates of no interest. High-pass 
temporal filtering was applied with a cutoff of 0.0078 Hz (1/128 seconds) in order to remove 
low frequency drift in the time series. For whole-brain analyses, the distributions were 
assumed to be normal but this was not formally tested for every voxel.
Group-level analysis were implemented using the general linear model in SPM8. We ran 
whole-brain analyses for the contrast of All Speech vs Rest within and between-groups and 
thresholded at a voxelwise FDR q<0.0572. For between-group region of interest (ROI) 
analysis we used meta-analytic ROIs from the Neurosynth term ‘language’73 of frontal and 
temporal cortex areas in both hemispheres, identical to those used in a prior paper19. We 
computed the difference in percent signal change for All Speech vs Rest and used this as the 
dependent variable in a linear model that tests subtype membership as the main independent 
variable of interest, while covarying for sex. Data are plotted in Fig. 2b for each individual to 
show the distribution of the data. No group showed heavy deviations from normality and all 
regions showed evidence of homogeneity of variance between groups. Follow-up tests for 
pairwise group comparisons used Welch’s t-test.
fMRI-Gene Expression Association Analysis
To assess multivariate fMRI-gene expression relationships we used partial least squares 
(PLS) analysis74, 75. PLS is widely used in the neuroimaging literature, particularly when 
explaining multivariate neural responses in terms of multivariate behavioral patterns of 
variation or a design matrix. Given that the current dataset is massively multivariate both in 
terms of fMRI and gene expression datasets, we used PLS to elucidate how variation in 
neural response to speech across large-scale neural systems covaries with gene expression as 
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measured by module eigengene values of co-expression modules. PLS allows for identifying 
such relationships by finding latent fMRI-gene expression variable pairs (LV) that 
maximally explain covariation in the dataset and which are uncorrelated with other latent 
fMRI-gene expression variable pairs. The strength of such covariation is denoted by the 
singular value (d) for each brain-behavior LV, and hypothesis tests can be made via using 
permutation tests on the singular values. Furthermore, identifying brain regions that most 
strongly contribute to each LV pair is made via bootstrapping, whereby a bootstrap ratio is 
created for each voxel, and represents the reliability of that voxel for contributing strongly to 
the LV pattern identified. The bootstrap ratio is roughly equivalent to a Z statistic and can be 
used to threshold data to find voxels that reliably contribute to an LV pair.
The PLS analyses reported here were implemented within the plsgui Matlab toolbox 
(www.rotman-baycrest.on.ca/pls/). Here we input first-level all speech versus rest contrast 
images into the PLS. For gene expression data, we input module eigengene values for all 21 
co-expression modules. For statistical inference on identified fMRI-gene expression LV 
pairs, a permutation test was run with 10,000 permutations. To identify reliably contributing 
voxels for fMRI-gene expression LVs and to compute 95% confidence intervals (CIs) on 
fMRI-gene expression correlations, bootstrapping was used with 10,000 resamples. To show 
voxels that most reliably contribute to significant fMRI-gene expression LVs, we 
thresholded data for visualization at a bootstrap ratio (BSR) of 1.96 and -1.96. The strength 
of fMRI-gene expression correlations for significant LVs was displayed as a bar graph with 
95% bootstrap CIs as error bars. Gene co-expression modules whereby 95% CIs do not 
encompass 0 are denoted as ‘non-zero’ association modules. All other modules where 95% 
CIs include 0 are denoted as ‘zero’ modules.
From the PLS results we tested whether non-zero associations across modules were common 
across ASD subtypes or common across ASD subtypes and TD. To test this question we 
counted the overlap amongst non-zero association modules in each group and ran 
hypergeometric tests that explicitly test for statistically significant overlap or commonality 
of non-zero associations across groups.
Enrichment Tests
Tests for functional (process-level) enrichment across all modules were implemented using 
the MetaCore GeneGO software platform. Further gene set enrichment tests 
(hypergeometric tests and enrichment odds ratio) were done on tissue-specific gene lists. 
First, we annotated each co-expression module by enrichment with 4 types of gene classes 
of relevance as defined by GTEx data reported from Boyle et al.20 These classes were 1) 
broadly expressed genes, 2) brain-specific genes, 3) whole-blood specific genes, and 4) 
lymphocyte-specific genes. The background pool number for these hypergeometric tests was 
14,313. Next, we tested whether non-zero modules were heavily enriched with modules 
from one or more of these gene classes. The background total for these tests was set to the 
total number of co-expression modules (e.g., 21).
Further enrichment tests were done across a wider range of gene lists of theoretical 
importance. Song birds are often used as animal models relevant for the vocal learning 
component of language25, 26, 33. We investigated enrichments with differentially expressed 
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genes taken from a microarray dataset of Area X of song birds33. To identify differentially 
expressed (DE) genes between singing versus non-singing birds, we re-analyzed this dataset 
(GEO Accession ID: GSE34819) using limma63, and DE genes were identified if they 
passed Storey FDR q<0.0564. Given the uniquely human nature of language, we also tested 
hypotheses regarding enrichments amongst genes that are transcriptionally different in the 
cortical tissue between humans and chimpanzees (i.e. human-specific genes). These tests 
were done across gene lists from two independent investigations on human-specific gene 
expression differences, where the common overlap amongst the two lists is small (4.38%)34, 
35. Ample evidence suggests that prenatal brain developmental periods are critical for 
ASD13, 36–38. To test enrichment with prenatal ASD-associated co-expression modules, 
we utilized co-expression modules from two independent studies that analyzed the Allen 
Institute BrainSpan dataset39 – 1) Eising et al., analyzed data from both subcortical and 
cortical regions and identified modules M3, M9, and M12 as ASD-associated and prenatally 
active36; 2) Parikshak et al., analyzed only cortical regions and identified M2 and M3 as 
ASD-associated and prenatally active37. There is 23% overlap between these two gene lists. 
We also tested enrichments with gene lists known to be associated with ASD, either via 
genetic evidence or evidence from cortical transcriptomic dysregulation. In particular, we 
examined de novo protein-truncating variants (dnPTV) associated with ASD48, ASD-
associated genes from the SFARI Gene (https://gene.sfari.org)50, and differentially 
expressed cortical co-expression modules measured from ASD post-mortem frontal and 
temporal cortex tissue40. For ASD-associated dnPTVs we used a list of 38 genes from 
Kosmicki et al.,48 with ≥2 dnPTVs in ASD and which also showed 0 dnPTVs in the 
normative ExAC database49. We additionally used a more relaxed criteria of ≥1 dnPTVs in 
ASD and 0 dnPTVs in ExAC combined with a probability of loss-of-function intolerance 
(pLI) ≥0.949, which resulted in 211 genes. Finally, we tested for enrichments with known 
downstream targets of highly penetrant mutations known to be associated with ASD – 
FMRP and CHD8. For each, we had lists of downstream targets for two independent 
studies76–79, where the overlap for FMRP targets was 3.71% and 27.61% for CHD8 
targets. FDR q<0.05 was used to identify significant enrichments after multiple comparison 
correction.
Co-expression Network Preservation Across ASD Brain and Blood Datasets
We also wanted to understand whether co-expression modules detected in blood leukocytes 
showed preservation of co-expression network patterns in ASD post-mortem cortical tissue 
from frontal and temporal cortex. To achieve this aim, we utilized ASD post-mortem frontal 
and temporal cortex RNA-seq data from Parikshak et al.,40. Using the same preprocessed 
data as Parikshak et al., we computed Zsummary module preservation statistics and 
evaluated which modules detected from ASD blood leukocyte datasets are preserved in ASD 
cortical frontal and temporal cortical tissue sampled from similar sites as those detected in 
the PLS LV1 map. Zsummary > 10 indicates strong preservation, while Zsummary between 
2 and 10 indicates moderate preservation67.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Clinical behavioral trajectories over the first 4 years of life in typically-developing (TD) 
toddlers and toddlers with ASD and good or poor early language outcome.
This figure shows developmental trajectories over the first 4 years of life for typically-
developing (TD) toddlers, toddlers with ASD and good early language outcome (ASD 
Good) and toddlers with ASD and poor early language outcome (ASD Poor) on clinical 
behavioral assessment measures such as ADOS total scores, Mullen Scales of Early 
Learning subscales (Expressive and Receptive Language, Visual Reception, and Fine Motor) 
and Vineland Adaptive Behavioral Scales (Communication, Socialization, Daily Living 
Skills, Motor, and Adaptive Behavior). The TD (n=35) group is shown in blue, ASD Good 
(n=40) in pink, and ASD Poor (n=41) in green. Individual level trajectories are plotted 
including the group-level trajectory and 95% confidence band.
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Figure 2. Reduced fMRI response to speech in ASD toddlers with poor early language outcome.
Panel A shows results of whole-brain analyses (one-tailed t-test) on each group separately 
(results shown at FDR q<0.05) (TD n = 37; ASD Good n = 40; ASD Poor n = 41). Panel B 
shows the results of region-of-interest (ROI) analyses testing for subtype differences. ROIs 
are defined by 4 regions within the Neurosynth ‘Language’ meta-analysis map in left (LH) 
or right hemisphere (RH) frontal and temporal cortex. ROI data are shown for each 
individual in the scatter-boxplots (TD, blue, n = 37; ASD Good, pink, n = 40; ASD Poor, 
green, n = 41). The box in the boxplots indicates the interquartile range (IQR; Q1 indicates 
the 25th, while Q3 indicates the 75th percentile) and the whiskers indicate Q1-(1.5*IQR) or 
Q3+(1.5*IQR). The line within the box represents the median. Matrices next to the scatter-
boxplots show standardized effect sizes (Cohen’s d) for each pairwise group comparison. 
Cohen’s d is shown in each cell and also indicated by the color of the cell. Within each cell 
one star (*) indicates p<0.05, while two stars (**) indicates p<0.005.
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Figure 3. Multivariate gene co-expression-fMRI association in ASD with good or poor early 
language outcome and typically-developing control toddlers.
Panel A shows the brain regions with the strongest contributions to the multivariate gene co-
expression–fMRI association present in the LV1 PLS result. The coloring in each region 
indicates the bootstrap ratio (BSR) and reflects how important each voxel is to the LV1 PLS 
result. Areas are shown in panel A if the BSR ≥ 1.96 or BSR ≤ -1.96. Hot colored regions in 
panel A are interpreted as showing a positive gene co-expression–fMRI correlation — that 
is, as a module’s eigengene increases, functional activation in response to speech also 
increases. In contrast, cool colored areas in panel A indicate a negative correlation between a 
module’s eigengene and functional activation response to speech. The table in panel B 
describes which modules were the strongest contributors to the LV1 PLS result. Each row 
indicates one of the 21 co-expression modules used in the PLS analysis. The columns 
labeled with the heading ‘Non-Zero Modules’ are broken down to indicate gene co-
expression–fMRI correlations by group. Cells in these columns are colored red or blue if the 
gene co-expression–fMRI correlation was non-zero and had 95% confidence intervals 
(estimated from bootstrapping) that did not include a correlation of 0. These modules are 
called ‘non-zero’ modules, as they are the strongest contributors or modules of importance 
to the LV1 PLS result. All other modules with white colored cells are labeled ‘zero’ 
modules, as the 95% confidence intervals for the gene co-expression–fMRI correlation 
include 0. Non-zero modules have cells colored in red to indicate a positive gene co-
expression–fMRI correlation (i.e. congruent with the interpretation already stated for the hot 
and cool colored regions in panel A). However, in the case of non-zero modules with cells 
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colored in blue, the previously stated way to interpret the hot and cool colored regions in 
panel A should reverse (e.g., cool colored regions in panel A reflect positive correlations 
with a module’s eigengene, while hot colored regions in panel A reflect negative correlations 
with a module’s eigengene). The remaining columns in panel B with the heading ‘Biological 
Processes’ annotate each module for enrichments in biological process terms from Metacore 
GeneGO software. Cyan colored cells indicate modules with enrichments passing FDR 
q<0.05 for multiple comparison correction. For a complete description of these biological 
process enrichments, please see Supplementary Table 5.
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Figure 4. Tissue class enrichments with sets of non-zero or zero association modules.
Enrichments with different classes of genes taken from the Boyle et al., (2017)20 analysis of 
tissue-specific or broadly expressed genes from GTEx data. Within panel A, the numbers in 
each cell represent the enrichment odds ratio, while the coloring represents the –log10 p-
value for each hypergeometric test for enrichment. Cells outlined in green pass multiple 
comparison correction at FDR q<0.05. In panel B, we show all gene co-expression modules 
(rows) and whether they are enriched for each tissue class (columns). Modules with 
enrichments passing FDR q<0.05 for multiple comparison correction are indicated as 
colored cells. The first 3 columns show which modules are those with non-zero associations 
(colored cells), as shown in Fig. 3b.
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Figure 5. Vocal learning, human-specific, and ASD-associated enrichments with sets of broadly 
expressed genes and non-zero or zero association modules.
Panel A shows the results of hyperogeometric tests for enrichment between broadly 
expressed genes, non-zero, and zero modules (columns) and a variety of different gene lists 
(rows) relevant to vocal learning, human-specific genes, or genes of relevance to ASD. The 
numbers in each cell represent the enrichment odds ratio, while the coloring represents the –
log10 p-value for each hypergeometric test for enrichment. For details about the gene lists 
specified in each row, see the Methods section. Cells outlined in green pass multiple 
comparison correction at FDR q<0.05. Panel B shows a table to indicate which gene co-
expression modules (rows) are enriched for a variety of different gene lists (columns). 
Modules with enrichments passing FDR q<0.05 for multiple comparison correction are 
indicated as cyan colored cells. The first 3 columns show which modules are those with non-
zero associations (colored cells), as shown in Fig. 3b.
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